Search For

The cross-talk between neurodegeneration and metabolic disorders

Research and clinical trial design in patients with metabolic dysfunction and alcohol-associated steatotic liver disease (MetALD): a narrative review

Evolving trends and drug class dynamics in drug-induced fatty liver disease over two decades

Yohimbine attenuates oxidative stress through circGNB1/CDA1 axis in diabetic nephropathy

Stage dependent management of sleeve gastrectomy leaks - a systematic review with proposed classification and management algorithm

Intermittent fasting-induced amelioration of thyroid hormone sensitivity was associated with improvements in insulin sensitivity independent of weight loss in steatotic liver disease

Association of exposure to phenols, pesticides, and phthalates with hepatic steatosis and MASLD in adolescents: the potential role of inflammation and lifestyle factors

Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease

The effects of glycated hemoglobin and body mass index on the relationship between the hemoglobin glycation index and the hypoglycemia risk: a moderated mediation analysis

Will a “multivitamin” a day keep the “MASLD doctor” away?

Cumulative metabolic, behavioral, and early-life factors for MASLD in Chinese children with validation in U.S. adolescents

The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036